Medicine and Dentistry
Cancer Cell
100%
Non Small Cell Lung Cancer
100%
Osimertinib
100%
Cancer Associated Fibroblast
60%
MEK Inhibitor
33%
Trametinib
33%
Epidermal Growth Factor Receptor
26%
Tumor Suppressor Protein
20%
Mitogen Activated Protein Kinase 1
20%
Metastatic Carcinoma
13%
Neoplasm
13%
Cell Proliferation
13%
Epidermal Growth Factor Receptor Kinase Inhibitor
13%
Xenograft
13%
Growth Inhibition
13%
Signal Transduction
13%
Malignant Neoplasm
6%
Interleukin-6
6%
Tumor Cell
6%
Programmed Cell Death
6%
Cell Growth
6%
Smooth Muscle Actin
6%
Fibroblast
6%
Receptor Expression
6%
Cell Survival
6%
Upregulation
6%
Tumor Progression
6%
Catenin
6%
Tumor Invasion
6%
Tyrosine-Kinase Inhibitor
6%
Lung Adenocarcinoma
6%
Scatter Factor
6%
Lung Fibroblast
6%
Platelet Derived Growth Factor Receptor
6%
The Cancer Genome Atlas
6%
Binding Site
6%
Biochemistry, Genetics and Molecular Biology
Cancer Cell
100%
Fibroblast
100%
Epidermal Growth Factor Receptor
54%
PDCD4
45%
Trametinib
45%
MEK Inhibitor
45%
Tumor Suppressor Protein
27%
Signal Transduction
18%
Cell Proliferation
18%
Tumor Progression
18%
Growth Inhibition
18%
Interleukin-6
9%
Binding Site
9%
Receptor Tyrosine Kinase Inhibitors
9%
Growth Factor Receptor Inhibitor
9%
STAT3
9%
Upregulation
9%
Cell Survival
9%
Tyrosine Kinase Inhibitor
9%
Coculture
9%
Platelet-Derived Growth Factor Receptor
9%
Actin
9%
Catenin
9%
Interleukin 8
9%
Hepatocyte Growth Factor
9%
Pharmacology, Toxicology and Pharmaceutical Science
Non Small Cell Lung Cancer
100%
Osimertinib
100%
Malignant Neoplasm
66%
Mitogen Activated Protein Kinase Kinase Inhibitor
33%
Trametinib
33%
Epidermal Growth Factor Receptor
26%
Tumor Suppressor Protein
20%
Mitogen Activated Protein Kinase 1
20%
Neoplasm
20%
Epidermal Growth Factor Receptor Kinase Inhibitor
13%
Tumor Growth
6%
Binding Site
6%
Catenin
6%
Platelet Derived Growth Factor Receptor
6%
Lung Adenocarcinoma
6%
Protein Tyrosine Kinase Inhibitor
6%
Tumor Invasion
6%
Scatter Factor
6%
Smooth Muscle Actin
6%